273 related articles for article (PubMed ID: 17239838)
1. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
Sjöwall C; Wetterö J
Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL
Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.
Tan Y; Yu F; Yang H; Chen M; Fang Q; Zhao MH
Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001
[TBL] [Abstract][Full Text] [Related]
5. Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndrome.
Wetterö J; Nilsson L; Jonasson L; Sjöwall C
Clin Chim Acta; 2009 Feb; 400(1-2):128-31. PubMed ID: 18973750
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271
[TBL] [Abstract][Full Text] [Related]
7. Biological markers in inflammatory rheumatic diseases.
Hilliquin P
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):993-1006. PubMed ID: 8747080
[TBL] [Abstract][Full Text] [Related]
8. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
Mevorach D
Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein and the acute phase response.
Gewurz H; Mold C; Siegel J; Fiedel B
Adv Intern Med; 1982; 27():345-72. PubMed ID: 7041546
[TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
13. A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus.
Seelen MA; van der Bijl EA; Trouw LA; Zuiverloon TC; Munoz JR; Fallaux-van den Houten FC; Schlagwein N; Daha MR; Huizinga TW; Roos A
Rheumatology (Oxford); 2005 Jan; 44(1):111-9. PubMed ID: 15479757
[TBL] [Abstract][Full Text] [Related]
14. Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus.
Augusto JF; Onno C; Blanchard S; Dubuquoi S; Mantovani A; Chevailler A; Jeannin P; Subra JF
Rheumatology (Oxford); 2009 Apr; 48(4):442-4. PubMed ID: 19213851
[No Abstract] [Full Text] [Related]
15. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
16. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
[TBL] [Abstract][Full Text] [Related]
17. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
Sjöwall C; Wetterö J; Bengtsson T; Askendal A; Almroth G; Skogh T; Tengvall P
Biochem Biophys Res Commun; 2007 Jan; 352(1):251-8. PubMed ID: 17113035
[TBL] [Abstract][Full Text] [Related]
18. C-Reactive protein and its implications in systemic lupus erythematosus.
de Carvalho JF; Hanaoka B; Szyper-Kravitz M; Shoenfeld Y
Acta Reumatol Port; 2007; 32(4):317-22. PubMed ID: 18159197
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
Flierman R; Daha MR
Mol Immunol; 2007 Jan; 44(1-3):133-8. PubMed ID: 16870257
[TBL] [Abstract][Full Text] [Related]
20. Antibody to serum amyloid A.
Rosenau BJ; Schur PH
J Autoimmun; 2004 Sep; 23(2):179-82. PubMed ID: 15324936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
